INHIBITION OF PROLIFERATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY NOVEL HETEROPOLYOXOTUNGSTATES INVITRO

被引:64
|
作者
TAKE, Y
TOKUTAKE, Y
INOUYE, Y
YOSHIDA, T
YAMAMOTO, A
YAMASE, T
NAKAMURA, S
机构
[1] HIROSHIMA UNIV,SCH MED,INST PHARMACEUT SCI,1-2-3 KASUMI,MINAMI KU,HIROSHIMA 734,JAPAN
[2] TOKYO INST TECHNOL,RESOURCES UTILIZAT RES LAB,TOKYO 152,JAPAN
[3] HIROSHIMA UNIV,SCH MED,DEPT MICROBIOL,HIROSHIMA 734,JAPAN
[4] TERUMO CO LTD,DIV RES & DEV,TOKYO,JAPAN
关键词
HETEROPOLYOXOTUNGSTATE; PM-19; KEGGIN STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS TYPE-1;
D O I
10.1016/0166-3542(91)90029-Q
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Fifteen heteropolyoxotungstates were tested for their effects on the proliferation of human immunodeficiency virus type 1 (HIV-1) using an in vitro system consisting of MT-4 cells and HTLV-III(b). Eight heteropolyoxotungstates (HPOTs) with the Keggin structure or dimerized deficient Keggin structure proved to be potent inhibitors of HIV-1. In contrast, seven non-Keggin HPOTs including HPA 23 did not have significant effects on HIV-1 proliferation at non-toxic doses. [PTi2W10O40]7-(PM-19) was the most potent inhibitor of HIV-1 among the 15 HPOTs tested. The inhibition of HIV-1 replication by PM-19 presumably results from impaired virus adsorption and/or penetration into target cells. Viral spread of HIV-1 and HIV-2 on cell-to-cell basis was also susceptible to PM-19. In combination, PM-19 and 3'-azido-3'-deoxythymidine were synergistic in inhibiting HIV-1 proliferation.
引用
收藏
页码:113 / 124
页数:12
相关论文
共 1 条